Published on 15 Nov 2022 on Zacks via Yahoo Finance
Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
Finch Therapeutics Group, Inc. (FNCH) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -12.50%. A quarter ago, it was expected that this company would post a loss of $0.46 per share when it actually produced a loss of $0.48, delivering a surprise of -4.35%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.